|
Post by peppy on Apr 6, 2017 7:05:56 GMT -5
Effort > results When a doctor doesn't care to put forth the time and effort to help improve a patient's disease, does this also influence the patient's mindset? Endocrinologist says they love it but it takes time and effort. The world isn't gonna end tomorrow (I don't think) so we have all the time we need. Putting forth the effort to ensure long term happiness for patients should never be an excuse for not putting in the time to see it happen. Endocrinologists that have been continuously prescribing the same diabetes drugs by the same diabetes companies for decades—just camouflaged under new names/uses—that produce the same pathetic outcomes and long term diabetes related complications, need a butt whooping in the meaning of health and care. Mango! let it be so! Cutting away from the non inferior label and standards of care and ensuing insurance coverage; What is not to love. A fast acting mealtime insulin that stops glucose from going high in the first place which is the key. Our users reporting, the key to afrezzaguy continuous glucose monitor he is always stays in range. He uses less afrezza that way. that was a stumper. So endocrinologist. Some times the smartest of the smart. They have brains. They have a lot more brains than I have. When I look at the glucose monitors, the difference between the subq fast acting, and afrezza is in plain and plane site. So these physicians are way smarter than I am. Additionally, they have eye balls. Did I just accidentally come across the problem? Balls? They are endocrinologists. I am bad. And this time and effort bullchit. Afrezza so much easier to learn than subq dosing. These people need to learn a new system, oh the effort.
|
|
|
Post by oldfishtowner on Apr 6, 2017 8:10:47 GMT -5
Effort > results When a doctor doesn't care to put forth the time and effort to help improve a patient's disease, does this also influence the patient's mindset? Endocrinologist says they love it but it takes time and effort. The world isn't gonna end tomorrow (I don't think) so we have all the time we need. Putting forth the effort to ensure long term happiness for patients should never be an excuse for not putting in the time to see it happen. Endocrinologists that have been continuously prescribing the same diabetes drugs by the same diabetes companies for decades—just camouflaged under new names/uses—that produce the same pathetic outcomes and long term diabetes related complications, need a butt whooping in the meaning of health and care. Mango! let it be so! Cutting away from the non inferior label and standards of care and ensuing insurance coverage; What is not to love. A fast acting mealtime insulin that stops glucose from going high in the first place which is the key. Our users reporting, the key to afrezzaguy continuous glucose monitor he is always stays in range. He uses less afrezza that way. that was a stumper. So endocrinologist. Some times the smartest of the smart. They have brains. They have a lot more brains than I have. When I look at the glucose monitors, the difference between the subq fast acting, and afrezza is in plain and plane site. So these physicians are way smarter than I am. Additionally, they have eye balls. Did I just accidentally come across the problem? Balls? They are endocrinologists. I am bad. And this time and effort bullchit. Afrezza so much easier to learn than subq dosing. These people need to learn a new system, oh the effort.
Note that the article from which the quote was taken was published in 2015 a mere 6 months after the Sanofi launch. Spirometry and insurance were much more of a problem. Even finding a pharmacy that had Afrezza. Only 4-unit sample packs, no guidance on titration and no titration packs. No MNKD Cares. Hopefully, Dr. Marcus would have a different opinion today.
|
|
|
Post by harryx1 on Apr 6, 2017 17:15:52 GMT -5
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Apr 7, 2017 4:54:00 GMT -5
I suspect Chicago's event is the reason for the recent brutal short attack. I expect to hear good things from Saturday's event; stay tuned!
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Apr 8, 2017 6:37:34 GMT -5
Cubs opening day and ADA Expo, Rahm's planners know how to coordinate events to maximize $. Liane, don't you wish you could be here today?
|
|
|
Post by liane on Apr 8, 2017 6:52:45 GMT -5
Yes I do. Funny thing is that I'm often in the Chicago area at this time of year (visiting my mom). It just was not possible this year.
|
|
|
Post by peppy on Apr 8, 2017 7:23:16 GMT -5
I suspect Chicago's event is the reason for the recent brutal short attack. I expect to hear good things from Saturday's event; stay tuned! kastanes, in the nicest way, you better download the events, when the event is finished.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Apr 8, 2017 7:33:10 GMT -5
peppy Unfortunately, I have to work so I will not be able to attend. A co-worker, T2, is planning on going. If he does I will provide feedback next week.
|
|
|
Post by harryx1 on Apr 8, 2017 9:12:11 GMT -5
|
|
|
Post by mnkdfann on Apr 8, 2017 9:17:05 GMT -5
Bringing out the heavy guns! (So to speak.)
|
|
|
Post by od on Apr 8, 2017 9:39:20 GMT -5
Can someone explain why folks believe the annual Chicago ADA will be special for Afrezza? I want to believe, but it is (just) another health fair that will raise awareness to attendees and, to the extent local media covers, the local community. Will it help, sure, but more irrational exuberance here, don't you think?
|
|
|
Post by kc on Apr 8, 2017 11:14:31 GMT -5
OD you are correct it's just another health fair sponsored by the ADA and all the big pharma players are there. It's all about visibility.
|
|
|
Post by ssiegel on Apr 8, 2017 11:18:05 GMT -5
OD you are correct it's just another health fair sponsored by the ADA and all the big pharma players are there. It's all about visibility. Is there any evidence these meetings are having any effect on prescription numbers? Also, are they attending the big ADA meeting in June? I can't find that they have acquired a booth yet.
|
|
|
Post by kc on Apr 8, 2017 11:19:43 GMT -5
You can bet they will be there and have a booth. History shows they purchased booth space at the last minute like they did last year.
Here is the 2017 ADA convention Floor space as of 8/26/2016 www.afassanoco.com/ada/currentfloorplan.pdf
Many companies book right after the last show and many wait until the last 60 days. So don't read anything into not having a booth yet.
You can look at the floor plan and speculate on where MannKind might be space wise. Last Year they purchased in early May and ended up next to a product theater.
here is their new interactive convention floor plan : www.expocad.com/host/fx/afassanoco/17ada/default.html
|
|
|
Post by lakers on Apr 8, 2017 11:23:01 GMT -5
www.diabetes.org/in-my-community/diabetes-expos/chicago/Chicago CBS 2 is the official Media partner. Hope they will provide an online video of the 4/8/2017 ADA event with interviews. Afrezza is listed as sponsor instead of the company Mannkind as opposed to Lilly, Novo. Is Afrezza going to be spun off as a separate company? Does it mean TS pipelines will be sold to RLS, Lily, Novo, Mylan, UTHR, CBD investors for at least $0.5B to finance Afrezza ? I prefer this so that we finally untangle from the starving vicious circle to properly commercialize, conduct trials for Afrezza for Ped, titration, time in range, UR labels. I always think Mnkd can't have it both ways and survive. It needs to sell TS pipelines for A to succeed. Mnkd can't nickel and dime, dink and dunk its way out of the perpetual starvation any longer. A needs at least 3 more years to succeed. See Matt's comparative chart. Thus it needs to be sufficiently financed, 0.5B - Notes. Is that why no additional share was proposed at 5/18 ASM in Danbury considering Mnkd has Notes due in a few months and runs out of cash this July? Mnkd said, Understandably, there are many parties who are waiting to see if Afrezza is adopted by the US and will be around. There are also many parties who want to be the first to introduce Afrezza in their regions. While there are ongoing discussions, our corporate policy is not to announce any material developments until there is definitive progress (translated to legally bounded agreements). Once potential international partners realize that A will be around for a foreseeable future, they will jump it with both feet. Success begets more success. www.diabetes.org/in-my-community/diabetes-expos/chicago/speaker-schedule.htmlMain Stage Schedule 10:15 a.m. to 11:00 a.m. New Perspective on Diabetes Kanika Ghai, MD, Division Director Pediatric Endocrinology Presented by Meridian 11:10 a.m. to 11:40 a.m. Find Your Voice With Mike Golic Former Professional Football Player & Sports Host Presented by Janseen 11:45 a.m. to 12:30 p.m. Taking the Stage to Shine a Light on Diabetes Legendary Entertainer Ben Verreen Presented by Novo Nordisk 12:35 p.m. to 1:20 p.m. Diabetes in Geriatrics Abrar Husain, MD Presented by Jencare 1:25 p.m. to 2:10 p.m. The Ins and Outs of Adding Inhaled Mealtime Insulin to the Type 2 Plan Alan Marcus, MD, FACP, FACE South Orange County Endocrinology Hip Hop, Movie Mogul and Diabetes Advocate Damon Dash Presented by Afrezza 2:15 p.m. to 2:45 p.m. DME Ambassador Stephen T. Presented by Regeneron 2:45 p.m. to 3:15 p.m. The ABCs of Diabetes Farah Hasan MD, FRCP, FACE, FACP, Center for Advanced Care at Orland Park, University of Chicago Medicine Hope the last speaker discuss Afrezza as well.
|
|